Drug Shortage Report for MYLAN-LOSARTAN HCTZ
Report ID | 7031 |
Drug Identification Number | 02378086 |
Brand name | MYLAN-LOSARTAN HCTZ |
Common or Proper name | LOSARTAN HCTZ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 12.5MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BL, 100BT |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-01 |
Actual start date | 2018-05-01 |
Estimated end date | Unknown |
Actual end date | 2018-05-01 |
Shortage status | Resolved |
Updated date | 2018-08-23 |
Company comments | Discontinued in ID 7031 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-04-13 | French | Compare |
v1 | 2017-04-13 | English | Compare |